港股早評:三大指數高開 科技股普升 京東開升超4%
特朗普稱股市將會大幅上升,隔夜美股三大指數升跌不一。港股三大指數高開,恒指升0.9%,國指升0.99%,恒生科技指數升1.58%。盤面上,昨日低迷的大型科技股集體上升,其中,京東升超4%,百度升近2%,美團、阿里巴巴、騰訊、小米升超1%;生物醫藥股繼續昨日上升行情,諾誠健華大升近10%,君實生物、藥明康德等皆上升,中藥股固生堂升5%;機器人概念股、汽車股、海運股、光伏股、家電股、體育用品股齊升。另一方面,黃金股、內險股部分下跌,建議配售新H股及控股股東擬以配售方式出售公司若干H股,微創機器人跌超10%。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.